Differences in VigiBase reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Differences in VigiBase reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Sagwa EL, Souverein Pc, Ribeiro I, Leufkens HG, Mantel-Teeuwisse AK.
Pharmacoepidemiol Drug Saf. 2016 Nov 20. doi:10.1002/pds.4125.
2016
http://onlinelibrary.wiley.com/doi/10.1002/pds.4125/abstract
Outcomes from the first 6 years of operation of the Central Portugal Pharmacovigilance Unit.
Outcomes from the first 6 years of operation of the Central Portugal Pharmacovigilance Unit.
Batel Marques F, Penedones A, Mendes D, Alves C.
J Patient Saf. 2016 Dec 16. doi:10.1097/PTS.0000000000000273.
2016
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=Ym2Q62vBJj17YlTnBZThzl2tzsCQTr1hSVXnpct56By06TNTfRKx!1080955772!181195628!8091!-1?sid=WKPTLP:landingpage&an=01209203-900000000-99555
Obesity and brain inflammation: a focus on multiple sclerosis
Obesity and brain inflammation: a focus on multiple sclerosis
Palavra F, Almeida L, Ambrósio AF, Reis F
Obesity Reviews (2016) 17, 211224
2016
Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressureinduced transient ischemic injury
Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressureinduced transient ischemic injury
Madeira MH, Boia R, Elvas F, Martins T, Cunha RA, Ambrósio AF, Santiago AR
Translational Research 2016; 169:112128
2016
Inside the Diabetic Brain: Role of Different Players Involved in Cognitive Decline
Inside the Diabetic Brain: Role of Different Players Involved in Cognitive Decline
Gaspar JM, Baptista FI, Macedo MP, Ambrosio AF
ACS Chem. Neurosci. 2016; 7, 131−142
2016
Therapeutic Opportunities for Caffeine and A 2A Receptor Antagonists in Retinal Diseases
Therapeutic Opportunities for Caffeine and A 2A Receptor Antagonists in Retinal Diseases
Boia R, Ambrósio AF, Santiago AR
Ophthalmic Res. 2016; 55:212218
2016
Protective Effect of a GLP-1 Analog on Ischemia- Reperfusion Induced BloodRetinal Barrier Breakdown and Inflammation
Protective Effect of a GLP-1 Analog on Ischemia- Reperfusion Induced BloodRetinal Barrier Breakdown and Inflammation
A Gonçalves, CM Lin, A. Muthusamy, C Fontes-Ribeiro, AF Ambrósio, SF Abcouwer, R Fernandes and DA Antonetti
Invest Ophthalmol Vis Sci. 2016;57:25842592. DOI:10.1167/iovs.15-19006
2016
Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
MH Madeira, A Ortin-Martinez, F Nadal-Nícolas, AF Ambrósio, M Vidal-Sanz, M Agudo-Barriuso and AR Santiago
Scientific Reports. 6:27532. DOI: 10.1038/srep27532
2016
The Adenosinergic System in Diabetic Retinopathy
The Adenosinergic System in Diabetic Retinopathy
J Vindeirinho, AR Santiago, C Cavadas, A F Ambrósio and P F Santos
Volume 2016 (2016), Article ID 4270301, 8 pages
2016
Modeling Human Glaucoma: Lessons from the in vitro Models
Modeling Human Glaucoma: Lessons from the in vitro Models
Aires I, Ambrósio AF, Santiago AR
Ophthalmic Res. 2016. DOI: 10.1159/000448480
2016